Blueprint Medicines Corp Aktie
-
Deine Einschätzung
Blueprint Medicines Corp Aktie
Was spricht für und gegen Blueprint Medicines Corp in den nächsten Jahren?
Pro
Kontra
Rendite von Blueprint Medicines Corp im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - | - | - | - |
| United Therapeutics | -0,67 % | 0,37 % | 7,70 % | 83,28 % | 14,95 % | 129,96 % | 187,25 % |
| Ligand Pharmaceuticals | -1,68 % | -1,68 % | -2,22 % | 93,41 % | 6,02 % | 162,69 % | 35,33 % |
| Ionis Pharmaceuticals Inc. | 0,67 % | 0,74 % | 0,62 % | 157,27 % | -3,88 % | 102,42 % | 83,64 % |
Kommentare
News
Irresistible Change: How to Spot Real Growth
Phil Gilbert, serial entrepreneur and former general manager at IBM, joins this episode of Motley Fool Money to talk about his new book, Irresistible Change: A Blueprint for Earning Buy-In and
Offshore Titans: Transocean Buys Valaris for $5.8B
Transocean Ltd. (NYSE: RIG) has made the definitive move to cement its status as the undisputed leader in offshore drilling. By agreeing to acquire Valaris Limited (NYSE: VAL) in an all-stock
Why Ford's Deal With Amazon Is Bigger Than You Think
Ford Motor Company (NYSE: F) has made a groundbreaking move in automotive retail, announcing a partnership to sell its certified pre-owned (CPO) vehicles directly on Amazon (NASDAQ: AMZN).
This





